BackMedTech Acquisition - Warrants (18/12/2025) Overview

MedTech Acquisition - Warrants (18/12/2025) Cost of Revenue

Cost of Revenue analysis for MTACW.

Quarterly Cost of Revenue

$1.23M
17.73% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$6.70M
38.98% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)